- Hydresia(TM) G2 approved by leading European authority on natural/
organic certification -
TSX symbol: SBS

CALGARY, Oct. 6 /CNW/ - Botaneco Specialty Ingredients Inc. (Botaneco), a subsidiary of SemBioSys Genetics Inc. (SemBioSys), today announced that its second generation oleosome product, Hydresia(TM) G2, has been authorized by ECOCERT(R) as an approved raw material, complying with the standards for ecological and organic cosmetics. ECOCERT(R) is one of the largest organic control and certification organizations in the world and conducts inspections in over 80 countries. The company's primary focus is food and food products, cosmetics, detergents, perfumes, and textiles.

"Botaneco is dedicated to manufacturing its all-natural products to comply with the highest natural production standards while eliminating the use of chemicals and synthetics," said Andrew Baum, president and CEO of Botaneco's parent company, SemBioSys. "The ECOCERT(R) authorization validates our product and production process with the most internationally recognized symbol for natural and organic raw materials."

Hydresia(TM) G2 is a cold-process emulsifying system comprised of oleosomes, naturally occurring oil reservoirs derived from safflower seeds. Oleosomes are nature's warehouse, or storage facility, for the emollient oils, antioxidants and natural moisture barriers that serve to keep the skin soft, supple and young looking. Using a proprietary non-solvent aqueous extraction process, these oleosomes are isolated from the seed fully intact, and when used in skin care applications can provide lasting protection to the skin. Hydresia(TM) G2 is a natural, renewable replacement for hydrocarbon derived petrolatum, mineral oil and non-ionic surfactants.

About Botaneco Specialty Ingredients Inc.

Botaneco is the global developer and marketer of innovative oleosome-based ingredients to the personal care and OTC topical markets. As a technologically driven provider of high performance, proprietary oleosome-based ingredients, Botaneco is committed to developing innovative ingredients that offer multifunctional, tangible and documented benefits to both formulators and consumers. Botaneco's head office and manufacturing facility is located in Calgary, Canada and its satellite office in Bensalem, PA. More information is available and can be accessed at www.botaneco.ca.

About SemBioSys Genetics Inc.

With headquarters in Calgary, Alberta, SemBioSys Genetics Inc. is a biotechnology company developing protein-based pharmaceuticals for metabolic and cardiovascular diseases. The Company's lead pharmaceutical candidates are recombinant human insulin to serve the rapidly expanding global diabetes market and Apo AI, a next generation cardiovascular drug.